Key result
Novel interventional and device therapies offer viable alternatives for managing medication-resistant hypertension.
Why the study?
Do surgical, interventional, and device-based approaches improve blood pressure management in patients with medication-resistant hypertension?
Do surgical, interventional, and device-based approaches improve blood pressure management in patients with medication-resistant hypertension?
This review summarizes the historical evolution and current landscape of interventional and device-based therapies for patients whose hypertension cannot be managed by medical therapy alone.
These device-based therapies may provide salvage options for resistant hypertension; however, this review leaves open.
The prevalence of hypertension around the world has increased significantly with projections for an increasing major global burden of hypertension. Medication-resistant hypertension can be perplexing and frustrating. The existence of these difficult patients results in the need for additional approaches to treatment including surgery, percutaneous interventions, and device management. The sophistication of these techniques has progressed markedly and initial procedures such as classical sympathectomy and renal artery bypass are almost never performed. Newer techniques of angioplasty with stenting, renal artery denervation, and baroreflex activation therapy via electrical stimulation of the carotid baroreceptors are now in use with increasing evidence for significant benefit.
No takes yet. Share an insight, caveat, or question.
Saha et al. (2014) conducted a review in Medication-resistant hypertension. Surgical, percutaneous, and device interventions was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: